Max Weis is now president and chief operating officer of VitalPath, which specializes in complex catheters and precision ...

Peytant Solutions CEO John Schorgl explains how his device startup turned a complex FDA de novo application into a lasting ...

The Trump administration's cuts to NIH funding affected approiximately 1 in 30 clinical trials and more than 74 ,000 patients.